Crinetics Pharmaceuticals (CRNX) Profit After Tax (2017 - 2025)
Historic Profit After Tax for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Q3 2025 value amounting to -$130.1 million.
- Crinetics Pharmaceuticals' Profit After Tax fell 6932.76% to -$130.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$423.1 million, marking a year-over-year decrease of 5224.25%. This contributed to the annual value of -$298.4 million for FY2024, which is 3909.91% down from last year.
- According to the latest figures from Q3 2025, Crinetics Pharmaceuticals' Profit After Tax is -$130.1 million, which was down 6932.76% from -$115.6 million recorded in Q2 2025.
- In the past 5 years, Crinetics Pharmaceuticals' Profit After Tax ranged from a high of -$22.9 million in Q1 2021 and a low of -$130.1 million during Q3 2025
- Its 5-year average for Profit After Tax is -$61.2 million, with a median of -$54.2 million in 2023.
- Per our database at Business Quant, Crinetics Pharmaceuticals' Profit After Tax crashed by 2030.44% in 2023 and then tumbled by 6932.76% in 2025.
- Crinetics Pharmaceuticals' Profit After Tax (Quarter) stood at -$30.8 million in 2021, then crashed by 46.1% to -$45.0 million in 2022, then tumbled by 33.58% to -$60.1 million in 2023, then crashed by 34.11% to -$80.6 million in 2024, then plummeted by 61.41% to -$130.1 million in 2025.
- Its Profit After Tax was -$130.1 million in Q3 2025, compared to -$115.6 million in Q2 2025 and -$96.8 million in Q1 2025.